SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starfighters Space Inc

Starfighters Space (FJET) is trending with massive speculative interest following its recent IPO, driven by discussions around its low float and unique F-104 Starfighter launch approach for commercial space operations. The community is actively debating its potential as a multi-day runner and significant price appreciation, while some express skepticism regarding its early stage and limited financial data.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing a significant rally, propelled by an $816 million U.S. Space Development Agency contract for missile-tracking satellites and a record-breaking 21 successful Electron launches. The community is actively debating its valuation and sustainability, with many investors anticipating further gains from the growing space sector, while others are calling for a healthy pullback and profit-taking after its rapid ascent.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

Crypto asset 401JK is trending amid significant token staking and community enthusiasm, as users embrace its vision for early retirement outside traditional financial systems. The project is gaining traction as a movement on the Solana blockchain, fueled by its relatable narrative and recent platform verifications.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is trending on increasing speculation of a potential acquisition, particularly following reports that Apollo-backed Legendary is weighing a takeover. The company's recent spin-off from Starz positions it as an attractive pure-play content studio, with its valuable film library and upcoming major releases like the highly anticipated Michael Jackson biopic fueling community discussion and investor interest.

Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology to provide additional rainfall for industries, supranational organizations, countries, and localities. The company is headquartered in Naples, FL.

Rain Enhancement Technologies Holdco Inc. - Ordinary Shares - Class A

Rain Enhancement Technologies (RAIN) is trending amid widespread community discussion of a potent short squeeze setup, driven by an exceptionally low public float, high cost to borrow, and reported scarcity of short shares. Enthusiasm is building around the company's innovative weather enhancement technology, which has shown promising early results from U.S. installations and secured significant contracts, leading many to view the stock as deeply undervalued relative to its potential.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is a top trending stock after the FDA approved its oral Wegovy pill, establishing the first-ever GLP-1 pill for weight management in the U.S. The community is buzzing, viewing this as a 'game-changer' that provides a significant first-mover advantage over competitors, especially for patients who prefer pills over injections. This development is expected to reinforce Novo Nordisk's leadership in the rapidly expanding obesity market with an anticipated early January launch.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara (SVRA) is trending following positive Phase 3 IMPALA-2 trial results for its lead candidate, molgramostim, targeting autoimmune Pulmonary Alveolar Proteinosis (aPAP). While analysts have significantly raised price targets and the community sees huge potential for the first approved therapy in this rare lung disease, recent price action has sparked discussions around "sell the news" dynamics, institutional movements, and ongoing M&A speculation. Investors are keenly watching for the upcoming Biologics License Application submission and further market development plans for Molbreevi.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending as its board recently rejected an undervalued takeover offer from its CEO and confirmed receiving multiple competitive acquisition proposals. This news has ignited community excitement around a potential bidding war, with investors emphasizing the company's significant cash reserves and intrinsic asset value. Speculation is high regarding a substantial premium and a possible short squeeze, as the shipping sector shows strengthening rates.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight Protocol ($NIGHT) is witnessing a significant surge in trading volume and price, fueled by recent major exchange listings, a hyped airdrop, and growing anticipation around privacy-focused projects following SEC discussions. The community is actively discussing $NIGHT's innovative 'rational privacy' approach within the Cardano ecosystem, positioning it as a leading privacy-first blockchain for institutional adoption and expressing strong bullish sentiment for its future.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences is trending following several bullish analyst upgrades and a recent private placement financing. The community is deeply divided, with many speculating on its potential for extreme parabolic moves due to its low float and past volatility, while others voice concerns over dilution and what they perceive as an inflated valuation. This intense discussion reflects the broader market trend of rapid, dramatic price movements seen in other low-float biotech stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ENDRAs TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new...

ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction-associated liver disease...

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease...

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition

MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.

ENDRA Life Sciences (NDRA) on Monday announced an aggregate of $4.9 million in commitments for a private placement, which was led by institutional and cryptocurrency investors.The investors have agreed to buy 744,340 shares of common stock or prefunded warrants, and accompanying warrants under the agreement, Endra said. If all warrants are fully exercised for cash, the company will receive up to $14.4 million in proceeds, it said. The offering is expected to close on or about October 14. &nbsp;The proceeds of the placement will be used to launch a digital asset treasury strategy managed by digital asset manager Arca Investment Management, the company said. ENDRA also intends to accumulate cryptocurrency and complete the TAEUS pilot validation imaging study focused on certain chronic liver conditions. Thermo Acoustic Enhanced UltraSound, or TAEUS, is a technology being developed by the company to assess tissue fat content and monitor tissue ablation during minimally invasive procedures.The company also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251013346843/en/ENDRA-Life-Sciences-Announces-At-Market-Private-Placement-of-Up-to-%2414.4-Million-to-Launch-Digital-Asset-Treasury-Strategy-Managed-by-Leading-Crypto-Asset-Manager-Arca">announced</a> on Monday that it intends to add Arca’s Chief Investment Officer, Jeff Dorman, to its Digital Asset Advisory Board. The firm believes its new digital asset treasury strategy can compound returns and create flexible income to reinvest into cryptocurrency.<a href="https://stocktwits.com/symbol/NDRA">NDRA shares</a> traded 24% higher at the time of writing. On Stocktwits, retail sentiment around the stock rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.NDRA stock is up by 28% this year and by 10% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-tvardi-therapeutics-stock-plummet-pre-market/ch6SK9gR3ki">Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

What’s Driving The Rally In NDRA Stock Today?

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.

Equity

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.


Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

NDRA
ENDRA Life Sciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NDRA News

NDRAENDRA Life Sciences Inc